VGLL3 and metabolic dysfunction-associated steatohepatitis: Analysis of a GEO dataset (GSE126848) including 16 patients with NASH and 14 control patients42 showed that VGLL3 expression was significantly upregulated in the fibrotic livers of patients with NASH (Supplementary Fig. 4f).